BRIEF-Climb Bio Reports First Quarter 2025 Financial Results

Reuters
14 May
BRIEF-Climb Bio Reports First Quarter 2025 Financial Results

May 14 (Reuters) - Climb Bio Inc CLYM.O:

  • CLIMB BIO REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

  • CLIMB BIO INC - BUDOPRUTUG CLINICAL TRIALS IN PMN, ITP, SLE ON TRACK FOR 2025

Source text: ID:nGNX8Mby6b

Further company coverage: CLYM.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10